EME Blood Gas and Electrolyte Analyzers Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Blood gas analysis is performed for critically ill patient suffering from a respiratory or metabolic disorder. In blood gas analysis includes measurement of the amount of oxygen, carbon dioxide, and the acidity of pH in the blood as well as concentrations of other parameters such ascreatinine, electrolytes, glucose, hemoglobin, and lactate. Blood gas analyzers use electrodes to determine pH, partial pressure of carbon dioxide, and amount of oxygen in the blood. Imbalances in oxygen, carbon dioxide, and pH levels in blood can indicate the presence of certain medical conditions such as heart failure, hemorrhage, kidney failure, chemical poisoning, uncontrolled diabetes, or drug overdose.

Restraints of the EME Blood Gas and Electrolyte Analyzers Market

Major factors hampering the growth of the uveitis treatment market during the forecast period constitutes of limited studies on efficacy comparison of treating agents, and challenging manufacturing process.

Key features of the study:

• This report provides in-depth analysis of the EME blood gas and electrolyte analyzers market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
• It profiles leading players in the EME blood gas and electrolyte analyzers market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Abbott Laboratories, Medica Corporation, Nova Biomedical, Radiometer Medical ApS, F. Hoffmann-La Roche Ltd., Siemens Healthcare, Alere Inc., EKF Diagnostics, ERBA Diagnostics Mannheim GmbH, and Instrumentation Laboratories (Werfen).
• Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
• The EME blood gas and electrolyte analyzers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

EME Blood Gas and Electrolyte Analyzers Market, By Product:

• Blood Gas Analyzers
• Electrolyte Analyzers
• Combination Analyzers
• Consumables

EME Blood Gas and Electrolyte Analyzers Market, By Modality:

• Laboratory Analyzers
• Benchtop Analyzers
• Portable Analyzers

EME Blood Gas and Electrolyte Analyzers Market, By End User:

• Hospitals
• Diagnostic Centres
• Ambulatory Surgical Centres
• Clinics

EME Blood Gas and Electrolyte Analyzers Market, By Geography:

• Europe

By Country:

• U.K.
• Germany
• Italy
• France
• Spain
• Nordics
• Denmark
• Finland
• Iceland
• Norway
• Sweden
• Rest of Europe

o Middle East:

By Country:

• Saudi Arabia
• UAE
• Turkey
• GCC Countries
• Israel
• Rest of Middle East
• Company Profiles
• Abbott Laboratories*
• Company Overview
• Product Portfolio
• Financial Performance
• Key Strategies
• Recent Developments
• Medica Corporation
• Nova Biomedical
• Radiometer Medical ApS
• F. Hoffmann-La Roche Ltd.
• Siemens Healthcare
• EKF Diagnostics
• ERBA Diagnostics Mannheim GmbH
• Instrumentation Laboratories (Werfen)

“*” marked represents similar segmentation in other categories in the respective section.